Penthrox approved in The Netherlands and Bosnia & Herzegovina
5 May 2020
Penthrox approved in The Netherlands and Bosnia & Herzegovina.
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in The Netherlands and Bosnia & Herzegovina. The Marketing Authorisation issued by the Medicines Evaluation Board of the Netherlands and the Agency for Medicinal Products and Medical Devices of Bosnia & Herzegovina is for Penthrox® to be used for Emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.
The approval in the Netherlands is part of a set of four countries, including Greece, Hungary, and Malta.
Please refer to the following link for additional details – ASX Announcement – Latest Penthrox Approvals